Exclusive-Germany’s Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say
By Sabrina Valle and Patricia Weiss NEW YORK/FRANKFURT (Reuters) - Merck KGaA, the German healthcare and technology group, is in ...
Read moreDetailsBy Sabrina Valle and Patricia Weiss NEW YORK/FRANKFURT (Reuters) - Merck KGaA, the German healthcare and technology group, is in ...
Read moreDetails
